mosaic gp140 env trimers
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 5, 2018 (NCT03307915)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03816137 | Phase 1 | Mar 19, 2019 | Imperial College London, University of London |
| NCT03307915 | Phase 1 | Mar 5, 2018 | Harvard University, Janssen Pharmaceutica NV, Ragon Institute of MGH, MIT and Harvard, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Janssen Pharmaceutica NV | For profit | 1 | 1 | 1 | 2018 |
| Ragon Institute of MGH, MIT and Harvard | Academic/Hospital | 1 | 0 | 1 | 2018 |
| United States Army | Government | 1 | 0 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1